Lucentis 10 mg (Ranibizumab SOLUTION) 10 MG

Lucentis 10 mg is an intravitreal solution used to treat eye conditions. This medication, containing ranibizumab, is designed for specific ocular therapies. Learn more about its uses and effects.

Strength

10 MG

Pack Size

0.23ML

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lucentis 10 mg is primarily used for the treatment of certain eye conditions. It is often prescribed for age-related macular degeneration and other retinal disorders. Patients may wonder, 'What is Lucentis used for?' This solution is specifically formulated for intravitreal administration, targeting issues within the eye.

Side Effects

Lucentis 10 mg may cause common effects such as eye redness, floaters, or increased eye pressure. Some users might experience temporary vision changes. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Lucentis 10 mg should be handled with care, ensuring proper sterile techniques during administration. Patients should avoid rubbing their eyes after treatment. It's crucial to follow all safety guidelines provided by the healthcare professional.

Avoid Interactions

Lucentis 10 mg may interact with other medications, particularly those affecting the eyes. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.

Frequently Asked Questions

Lucentis 10 mg is used to treat certain eye conditions, including age-related macular degeneration and other retinal disorders.

Lucentis 10 mg is administered as an intravitreal injection, directly into the eye, by a healthcare professional.

Common side effects may include eye redness, floaters, and increased eye pressure. Temporary vision changes may also occur.

Patients should consult their healthcare provider before using Lucentis with other medications to avoid potential interactions.

Lucentis should be stored as per the manufacturer's instructions, typically in a refrigerator, to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.